Completed OBSERVATIONAL NCT03732872

Epithelial Mesenchymal Transition Markers in OSMF

Risk Assessment of Malignant Transformation in Oral Submucous Fibrosis Using Epithelial Mesenchymal Transition (EMT) Signatures in Tissue Samples and Saliva

Sponsor: Credora Life Sciences, India

Conditions Oral Submucous Fibrosis

Interventions Biopsy tissue analysis Saliva analysis

Updated 6 times since 2018 Last updated: Nov 4, 2018 Started: Jan 15, 2015 Primary completion: Dec 28, 2017 Completion: Mar 20, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03732872, this observational or N/A phase trial focuses on Oral Submucous Fibrosis and remains completed. Sponsored by Credora Life Sciences, India, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 1 earlier version

Dec 2018 — Nov 2020 [monthly]

Completed

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Credora Life Sciences, India
The Oxford Dental College, Hospital and Research Center, Bangalore, India

Data source: The Oxford Dental College, Hospital and Research Center, Bangalore, India

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.